in the ejaculate was considered suggestive for significant bacteriospermia. Semen analysis values were assessed based on 2010 World Health Organization reference criteria. EAU guidelines for semen culture (leukocytospermia >10 6 WBCs/mL, according to WHO classification) were used to predict positive semen culture in our cohort and thus validated. Moreover, we tested the predictive performance and accuracy of several clinical parameters and compared them to EAU guidelines RESULTS: Overall, a positive semen culture was found in 56 (10%) men. The most commonly identified pathogens belonged to the Enterobacteriaceae family (15% of all positive examinations). Of all, 141 (26%) patients had leukocytospermia >106 WBCs/mL and would have therefore deserved semen culture testing according to EAU guidelines; of them, 12 (9%) actually displayed a positive semen culture. Conversely, 44 (79%) out of 56 patients with positive semen culture would have been missed. Overall predictive accuracy, sensibility, and specificity of EAU guidelines were 48%, 21%, and 74% respectively. No further clinical parameter was significantly associated with positive sperm culture and could be therefore used as a predictor, except for increased serum neutrophil-to-lymphocyte (NRL) ratio (predictive accuracy 60%, p¼0.03 vs. EAU guidelines).
INTRODUCTION AND OBJECTIVES:
Temporal and spatial separation between transcription and translation of RNAs is a unique process necessary to complete spermatogenesis. During meiosis transcribed RNAs are sequestrated in nucleoprotein complexes with YBX2. In animal models, loss of YBX2 leads to male infertility due to loss of translational suppression. Based on our RNAseq data we hypothesize that loss of expression of YBX2 during meiosis is a cause of early and late maturation arrest (eMA and lMA) in humans.
METHODS: Next generation RNAseq was performed using human testis biopsies from men with non-obstructive azoospermia (NOA) (44) and 10 from normal controls (NLs) to identify differentially expressed genes. Expression of PRM1 and PRM2 RNAs occurs very early in spermatogenesis in normal men, and is correlated to expression of YBX2 RNA. To further confirm our hypothesis, we performed immunofluorescence co-localization of following proteins: YBX2, PRM1/PRM2 (spermatids), SYCP3 (spermatocytes), and PLZF or UTF1 (spermatogonia) in slides form infertile men with eMA or lMA, and NLs.
RESULTS: PRM1/2 expression was 1.99Eþ10 and SMCP 2.33Eþ10x lower in MA than in NLs, confirming loss of spermatids among MA tissue; however, both eMA and lMA demonstrated similar SYCP3 expression, suggesting a similar number of spermatocytes compared to NLs. YBX2 RNA expression was 207x less in men with eMA and lMA as compared to NLs. Considering that YBX2 is expressed early in normal spermatogenesis this finding was not explained by loss of cells, but rather indicated potential cause for MA. YBX2 was lost in spermatocytes from men with eMA and lMA as compared to NLs with only dim expression of YBX2 in few single cells was observed. Further experiments confirmed that YBX2 expression co-localized with SYCP3 positive spermatocytes in NLs but not in MA. This finding indicates that primary loss of YBX2 with subsequent arrest in spermatogenesis may be due to the lack of mRNAs necessary for exchange of histones to protamines. Hence we show for the first time in human tissues that loss of YBX2 is a plausible mechanism for maturation arrest.
CONCLUSIONS: In this study, we shoed downregulation of YBX2 gene expression and loss of YBX2 protein in spermatocytes from men with maturation arrest thus providing strong evidence that the loss of YBX2 despite preservation of SYCP3 expression is a culprit of maturation arrest in humans. Our next step is to reintroduce the YBX2 expression in early spermatocytes in culture thus offering therapeutic avenue for men with maturation arrest.
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MP60-15 TRANSCRIPTOME ANALYSIS TO IDENTIFY HUMAN SPERMATOGONIAL CELLS FROM SERTOLI CELL-ONLY TESTES
Koji Shiraishi*, Hideyasu Matsuyama, Ube, Japan INTRODUCTION AND OBJECTIVES: Non-obstructive azoospermia (NOA), particularly Sertoli cell-only (SCO), is the most severe form of male factor infertility and is classically thought to lack germ cells and spermatogenic stem cells (SSCs). However, evidence from microsurgical testicular sperm extraction (micro-TESE) on men with SCO has revealed the presence of focal areas of full spermatogenesis, suggesting the possible presence of SSCs in some patients with SCO lacking mature sperm. To determine whether gene products from SSCs could be detected in SCO, transcriptome analysis using next-generation sequencing (NGS) was performed using human biopsied testicular samples.
METHODS: Under IRB approval, testicular samples were obtained from 20 men (mean age: 35.7 years) with SCO in which no germ cells were found during laboratory examination and from five men with obstructive azoospermia (mean age: 38.5 years) with normal spermatogenesis. Men with sex chromosome or AZF abnormality were excluded. Transcriptomes on the Illumina platform were expressed as FPKM, and Cuffdiff analysis was performed to compare individual differences among testicular tissues from obstructive azoospermia (OA). Expression of mRNA and localization of targeted genes were confirmed by RT-PCR and immunohistochemical analyses, respectively. RESULTS: From the 23,003 genes screened with using NGS with a significant signal after background correction and normalization, a total of 5,666 genes were analyzed. As representative markers of immature germ cells, UTF1, OCT4, DDX4, MMP1, GFRa, GPX1, SCP3, CD14, KLF9, GFRA1 and KIT mRNA were detected in SCO samples by transcriptome analysis. RT-PCR showed significant mRNA expression of UTF1, OCT4, DDX4, SCP3 and KIT from SCO samples. Immunohistochemistry showed the localization of DDX4 and/or KIT-positive cells in the seminiferous tubules and basement membrane in eight (40%) of the SCO samples. All the gene products evaluated in SCO samples were present in testes with obstructive azoospermia. There was no significant difference in the patients' background and hormonal data between the men with and without DDX4 and/or KIT-positive cells.
CONCLUSIONS: Germ cells are present in 40% of SCO samples as immature forms, namely SSCs. These observations help our understanding of the pathophysiology of spermatogenic failure where germ cell development stops during early stages of spermatogenesis in some men with SCO. The azoospermia seen in men with SCO appears to be, at least in part, secondary to a defect in proliferation and differentiation of SSCs. None Vol. 199, No. 4S, Supplement, Sunday, May 20, 2018 THE JOURNAL OF UROLOGY â e795
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